Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3220716

O=C(N[C@@H]1CCC[C@H](c2nc3ccccc3[nH]2)C1)c1c[nH]c2ccccc12.O=C(O)C(F)(F)F

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.44
RAB9A P51151 3/20 0.43
NPC1 O15118 1/20 0.42
HTR3E A5X5Y0 1/20 0.42
HTR3B O95264 1/20 0.42
HTR3A P46098 1/20 0.42
HTR3D Q70Z44 1/20 0.42
HTR3C Q8WXA8 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HTT P42858 1/20 0.41
GID4 Q8IVV7 1/20 0.41
TPSAB1 Q15661 1/20 0.40
MAPT P10636 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CDK7 P50613 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13490700 0.94 SMN1; SMN2 (0.49) SMN1; SMN2RAB9ANPC1HTR3EHTR3B
Trifluoroacetic Acid SCHEMBL3210746 0.89 SMN1; SMN2 (0.47) SMN1; SMN2RAB9AKMT2AGID4MAPT
Trifluoroacetic Acid SCHEMBL3215916 0.86 SMN1; SMN2 (0.43) SMN1; SMN2RAB9AGID4MAPT
Trifluoroacetic Acid SCHEMBL3207659 0.85 NPC1 (0.57) SMN1; SMN2RAB9ANPC1HTR3AGID4
Trifluoroacetic Acid SCHEMBL3223498 0.85 NPC1 (0.57) SMN1; SMN2RAB9ANPC1HTR3AGID4
SCHEMBL13490513 0.83 SMN1; SMN2 (0.48) SMN1; SMN2RAB9ANPC1HTR3EHTR3B
Trifluoroacetic Acid SCHEMBL3210512 0.81 HTR2B (0.43) SMN1; SMN2GID4
Trifluoroacetic Acid SCHEMBL3209776 0.81 GID4 (0.40) SMN1; SMN2GID4
SCHEMBL14192814 0.81 SMN1; SMN2 (0.53) SMN1; SMN2RAB9ANPC1KMT2AGID4
SCHEMBL13490676 0.81 SMN1; SMN2 (0.53) SMN1; SMN2RAB9ANPC1KMT2AGID4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029615-A1 BENZIMIDAZOLE DERIVATIVES PFIZER INC. 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029615-A1 BENZIMIDAZOLE DERIVATIVES ACIN1, HAT1, CCNE1 SMN1; SMN2 746/4885RAB9A 1662/4885NPC1 3250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.